On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Retina Vitreous Associates Medical Group

InstitutionResearch output, impact & collaborations

Retina Vitreous Associates Medical Group is a institution indexed in ScholarIQ from OpenAlex.

What is known about Retina Vitreous Associates Medical Group?

ScholarIQrecord summary

Retina Vitreous Associates Medical Group is a research organisation in Beverly Hills, United States. OpenAlex records 465 works and 34,739 citations for it. 1 researchers list it as their most recent affiliation.

How many works does Retina Vitreous Associates Medical Group have?

ScholarIQindexed works

Retina Vitreous Associates Medical Group has 465 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Retina Vitreous Associates Medical Group have?

ScholarIQcitation count

Retina Vitreous Associates Medical Group has 34,739 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Retina Vitreous Associates Medical Group?

ScholarIQresearcher count

Retina Vitreous Associates Medical Group has 1 researchers in the ScholarIQ index.

What is the average h-index at Retina Vitreous Associates Medical Group?

ScholarIQavg h-index

Retina Vitreous Associates Medical Group has an average h-index of 66 in OpenAlex.

What is the ROR of Retina Vitreous Associates Medical Group?

ScholarIQror

The ROR for Retina Vitreous Associates Medical Group is on the source record.

What is the OpenAlex record for Retina Vitreous Associates Medical Group?

ScholarIQopenalex

The OpenAlex for Retina Vitreous Associates Medical Group is on the source record.

Who are the most-cited researchers behind Retina Vitreous Associates Medical Group?

ScholarIQtop researchers by citations
1
David S. Boyer · Retinal Diseases and Treatments
334 works27,813 citations

What are the most-cited papers on Retina Vitreous Associates Medical Group?

ScholarIQmost cited works
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
David Liao, F Grossi, Delphine El Mehdi, Monica Gerber, David M. Brown, Jeffrey S. Heier, Charles C. Wykoff, Lawrence J. Singerman, Prema Abraham, Felix Graßmann, Peter Nüernberg, Bernhard H. F. Weber, Pascal Deschatelets, Robert Y. Kim, Carol Chung, Ramiro Ribeiro, Mohamed Hamdani, Philip J. Rosenfeld, David S. Boyer, Jason S. Slakter, Cedric Francois
Ophthalmology. 2019522 CitationsOPEN ACCESS
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression
Emily Y. Chew, Traci E. Clemons, Elvira Agrón, Amitha Domalpally, Tiarnán D L Keenan, Susan Vitale, Claire Weber, Douglas C. Smith, William G. Christen, John Paul SanGiovanni, Federick L Ferris, Ronald P. Danis, Barbara A. Blodi, Alan Ruby, Andrew N. Antoszyk, Ronald Klein, Ivana K. Kim, Gary E. Fish, Wai T. Wong, David H. Orth, Kourous A. Rezaei, Susan B. Bressler, GB Hubbard, Michael J. Elman, Suresh Chandra, Thomas R. Friberg, Michael Tolentino, Darmakusuma Le, Mary B. Lansing, Jay B. Stallman, Paul Edwards, Carl W. Baker, Michael Novák, Ricky D. Isernhagen, Todd E. Schneiderman, Lawrence S. Halperin, Michael H. Lee, David S. Boyer, Philip J. Rosenfeld, Pamela Rath, Marc H. Levy, Robert H. Rosa, John C. Hoskins, Clement K. Chan, David M. Brown, Craig M. Greven, J Michael Jumper, Linda J. Margulies, William N. Rosenthal, Richard B. Rosen, Glenn Stoller, Fadi El Baba, W. Copley McLean, Ronald Kingsley, Alice T. Lyon, Jeffrey S. Heier, Anne E. Fung, Ingrid U. Scott, John A. Wells, Michael J. Banach, Paul M. Beer, James C. Folk, Joseph I. Maguire, Srinivas R. Sadda, Richard A. Garfinkel, Judy E. Kim, Paul Berstein, Michael Rauser, Richard A. Lewis, Barron C. Fishburne, Suber Huang, Nelson R. Sabates, Nicola Kim, Robert N. Frank, Brian C. Joondeph, Odette M. Houghton, Dean P. Hainsworth, Edward Chaum, Robert H. Millay, Raymond Iezzi, Rajendra S. Apte, Ron A. Adelman, Anita Agrawal, Neelakshi Bhagat, Lawrence Ulanski, Steven D. Schwartz, Cynthia Owsley, Alan Letson, Yu-Guang He, Cynthia A. Toth, Lawrence S. Morse, Michael J. Cooney, Sandeep Grover, Henry Ferreyra, Alexander J. Brucker, David DiLoreto, Aaron Weinberg
JAMA Ophthalmology. 2022176 CitationsOPEN ACCESS
Faricimab Treat-and-Extend for Diabetic Macular Edema
Tien Yin Wong, Zdenka Hašková, Kemal Asik, Caroline R. Baumal, Karl G. Csaky, Nicole Eter, Jane A. Ives, Glenn J. Jaffe, Jean‐François Korobelnik, Hugh Lin, Toshinori Murata, Paisan Ruamviboonsuk, Patricio G. Schlottmann, András Seres, David G. Silverman, Xiaodong Sun, Yannan Tang, John A. Wells, Young Hee Yoon, Charles C. Wykoff, Thomas M. Aaberg, Ashkan M. Abbey, Elmira Abdulaeva, Santiago Abengoechea, Prema Abraham, Thomas Ach, Serrhel G. Adams, Alfredo Adan Civera, Sean D. Adrean, Hansjürgen Agostini, Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel
Ophthalmology. 2023151 CitationsOPEN ACCESS

How much of the research on Retina Vitreous Associates Medical Group is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
67%
Bronze
0%
Closed
0%
470M+ articles · free account